LMG Life Sciences Ranks WilmerHale and Attorneys Among the Best

Download IconDownload Print IconPrint

LMG Life Sciences Ranks WilmerHale and Attorneys Among the Best

Firm News

Related Solutions

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
Helping clients launch their businesses and transform their innovative ideas into successful companies.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.
Clients trust us to protect their most important intellectual property matters.
A global team handling highly complex and sensitive matters in all aspects of litigation.
Providing comprehensive solutions for the acquisition, enforcement and protection of IP.
Intellectual Property Litigation
We advise clients on the smartest, most cost-effective ways to challenge or defend issued patents.

By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with laboratory and research teams and R&D and product development groups to determine whether, when and where it is in our clients’ business and technical interests to seek patent protection. And we don’t just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

We help clients obtain more than 750 US and foreign patents each year, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high-speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices and processes, and software.

We also prepare and prosecute patent applications internationally under the Patent Cooperative Treaty and by working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the US Patent and Trademark Office, the US Court of Appeals for the Federal Circuit and the European Patent Office.

Uncompromising defense of corporations and individuals in high-profile and complex litigation and investigations.

In its latest edition, LMG Life Sciences recognizes WilmerHale among the nation's leading life sciences law firms. The 2016 guide highlights nine firm practices and 18 attorneys, recognizing work under three categories—Intellectual Property, Finance and Transactional, and Non-IP Litigation and Enforcement. 

Praised by one client for its “impressive experience in the life sciences field, with a great understanding of the industry and first rate legal skills,” the firm continues to build on its reputation as a leading force in counseling life sciences companies.

LMG Life Sciences, a legal directory guide focusing on US law firms and attorneys who work with life sciences companies, is produced by the Legal Media Group and its editorial structure is divided into categories that cover traditional practice areas that relate to life sciences. Research for the publication was based on interviews and surveys completed by leading lawyers and clients who are active in the market.

WilmerHale is recognized in the following areas (separated by category):

Intellectual Property
Patent Prosecution – Recommended
Patent Strategy and Management – Highly Recommended
General Patent Litigation – Highly Recommended
Hatch-Waxman Patent Litigation – Highly Recommended

Finance & Transactional
Corporate – Recommended
Licensing & Collaboration – Highly Recommended
Mergers & Acquisitions – Recommended
Venture Capital – Recommended

Non-IP Litigation & Enforcement
White Collar/Government Investigations – Recommended

In addition, the below attorneys are identified as Life Sciences Stars.

David B. Bassett
Robert J. Gunther
William F. Lee
Lisa J. Pirozzolo
Mark D. Selwyn
Colleen Superko
Michael J. Twomey
Emily R. Whelan
Amy Wigmore
Steven D. Barrett
Belinda Juran
Steven D. Singer
Michael Bongiorno
Karen Green
Brent Gurney
Stephen Jonas
Emily Schulman
Howard Shapiro

View the LMG Life Sciences 2016 rankings.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel